Results 141 to 150 of about 12,902 (159)

Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke. [PDF]

Blood Adv
Patel RB, Jha AB, Jain A, Verma AK, Saini S, Muia J, Gurung P, Perlman S, Budnik I, Chauhan AK.   +9 more
europepmc   +1 more source

Delayed Recovery of a Disintegrin-Like and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) Activity in Immune Thrombotic Thrombocytopenic Purpura Treated With Caplacizumab and Rituximab. [PDF]

Cureus
Fujiwara Y, Okamoto M.
europepmc   +1 more source

More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura". [PDF]

Haematologica
Peyvandi F.
europepmc   +1 more source

Plasmapheresis and vasculitis affecting the kidney [PDF]

, 2015
Choi, Tom N
core   +1 more source

Tumour-Associated Microangiopathic Haemolytic Anaemia with Thrombocytopenia: A Narrative Review and Case Study. [PDF]

J Clin Med
Kovacic V, Mikacic M, Jerkovic I, Ilic Begovic T, Maras M.   +4 more
europepmc   +1 more source

A Thrombocytopenic Thrombotic Purpura in a Patient With a Metastatic HER2+ Breast Cancer: Description of a Case Report. [PDF]

Clin Case Rep
Longo R, Savenkoff B, Ribal R, Dadoun A, Campitiello M, Plastino F, Legros PO, Marcon N, Coppo P, Egea J.   +9 more
europepmc   +1 more source

Recurrent Multi-territorial Ischemic Stroke As the Initial Presentation of Thrombotic Thrombocytopenic Purpura. [PDF]

Cureus
Reichman N, Biso GMN, Masoud H.
europepmc   +1 more source

Irradiation with 265-nm Ultraviolet Light-Emitting Diodes to Plasma: Alterations of Hemostatic Parameters and von Willebrand Factor. [PDF]

Transfus Med Hemother
Hayashi T, Fujimura Y, Sakurai Y, Masaki M, Fuchizaki A, Oguma K, Hosokawa K, Mishima Y, Tanaka M, Yasui K, Kimura T, Tani Y, Hirayama F, Takahashi K, Takihara Y.   +14 more
europepmc   +1 more source

ADAMTS13 attenuates renal fibrosis by suppressing thrombospondin 1 mediated TGF-β1/Smad3 activation. [PDF]

Toxicol Appl Pharmacol
Guo J, Zhou S, Wang H, Qiu X, Dong F, Jiang S, Xu N, Cui Y, Liu R, Li P, Ma Z, Zhao L, Lai EY.   +12 more
europepmc   +1 more source